News & insights

News

Prioritising the Priority Claim

The Board of Appeal (BoA) recently issued its preliminary comments in preparation for Oral Proceedings in, arguably, the most high profile appeal at the EPO in recent years (T 0844/18).

Updates

Jeffrey Parker joins Kilburn & Strode to expand the firm’s offering

“We are delighted to welcome Jeffrey to our ranks. His flair and wealth of experience will further enhance our leading Trade Mark practice.”

Updates

Kilburn & Strode welcome 11 Trainee Patent and Trade Mark Attorneys and launch Paralegal Academy

Crossing a range of sectors and functional expertise, we’re very proud to announce the arrival of our new trainee attorneys. We are also excited to launch our new Paralegal Academy which saw us hire four IP Paralegals into the firm.

News

Good news - an update on ORKAMBI availability for cystic fibrosis patients in the UK

News last month reports that an agreement has now be made, after years of dispute, for patients in England to have access to ORKAMBI though NHS England. The drug was authorised over four years ago, but the price asked by Vertex was “unaffordable” according to the NHS.

News

Too big to pay – has Shanks v Unilever changed the way the courts interpret ‘outstanding benefit’?

On 23 October 2019, the Supreme Court handed down its judgment on whether Professor Ian Shanks is entitled to compensation under section 40 of the Patents Act 1977 for his contribution to an invention for determining blood sugar levels made while he was employed by Unilever.

News

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept

News & insights

Prioritising the Priority Claim

Jeffrey Parker joins Kilburn & Strode to expand the firm’s offering

Kilburn & Strode welcome 11 Trainee Patent and Trade Mark Attorneys and launch Paralegal Academy

Good news - an update on ORKAMBI availability for cystic fibrosis patients in the UK

Too big to pay – has Shanks v Unilever changed the way the courts interpret ‘outstanding benefit’?

Kilburn & Strode uphold Band 1 ranking in Chambers and Partners

Innovation Capture 101

Kilburn & Strode uphold Tier 1 ranking in Legal 500 for patents and trade marks

Mastering the business of patents

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.